← Leaderboards
Jaisri R Lingappa
University Of Washington
$10,736,726
Attributed
$10,736,726
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$10,736,726 · 10
By mechanism
R01$8,876,468 · 5
R21$889,153 · 2
R56$814,750 · 2
R29$156,355 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Lisa M Frenkel$29,105,317
- Rachel O Wong$25,926,105
- Geoffrey Scott Gottlieb$16,750,227
- Joanne Donna Stekler$9,601,472
- William Stafford Noble$23,955,785
Others in their field
Top investigators on “Hiv-1”
- Barton F Haynes · Duke University$476,288,740
- Lawrence Corey · Fred Hutchinson Cancer Center$445,419,385
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$294,186,693
- Constance Ann Benson · University Of California, San Diego$272,046,180
- Peter B. Gilbert · Fred Hutchinson Cancer Center$173,010,936
- Dan H. Barouch · Fred Hutchinson Cancer Center$166,542,502
Research focus
Hiv-1ProteinsComplexViralCellsCell LineCapsidAntiviral AgentsVirusT-LymphocyteLife Cycle StagesVirionSiteAffectGenomeAtp PhosphohydrolaseBinding ProteinsFuturePathway InteractionsBiochemicalGag Gene ProductsLeadEventInfection
Grant awards (34)
Understanding potent and novel small molecules that target HIV assembly$176,500
R21 · FY2021 · AI · contact PI
Understanding potent and novel small molecules that target HIV assembly$308,875
R21 · FY2020 · AI · contact PI
Interrogating complexes involved in HIV-1 assembly with biochemistry, imaging, and a small molecule$441,250
R56 · FY2019 · AI · contact PI
HIV packaging occurs in RNA granules: implications for cell biology and anti-retroviral drugs$348,588
R01 · FY2019 · AI · contact PI
HIV packaging occurs in RNA granules: implications for cell biology and anti-retroviral drugs$347,765
R01 · FY2018 · GM · contact PI
HIV packaging occurs in RNA granules: implications for cell biology and anti-viral drugs$153,935
R01 · FY2018 · GM · contact PI
HIV-1 capsid assembly intermediates: cellular factors and links to pathogenesis$435,000
R01 · FY2017 · AI · contact PI
HIV packaging occurs in RNA granules: implications for cell biology and anti-retroviral drugs$347,600
R01 · FY2017 · GM · contact PI
HIV-1 capsid assembly intermediates: cellular factors and links to pathogenesis$435,000
R01 · FY2016 · AI · contact PI
HIV packaging occurs in RNA granules: implications for cell biology and anti-retroviral drugs$345,954
R01 · FY2016 · GM · contact PI
HIV-1 capsid assembly intermediates: cellular factors and links to pathogenesis$435,000
R01 · FY2015 · AI · contact PI
HIV-1 capsid assembly intermediates: cellular factors and links to pathogenesis$435,000
R01 · FY2014 · AI · contact PI
HIV-1 capsid assembly intermediates: cellular factors and links to pathogenesis$408,509
R01 · FY2013 · AI · contact PI
Regulation of APOBEC3G enzymatic activity in HIV-infected primary human T cells$374,460
R01 · FY2012 · AI · contact PI
Regulation of APOBEC3G enzymatic activity in HIV-infected primary human T cells$379,729
R01 · FY2011 · AI · contact PI
The role of cellular factors in the HIV-1 capsid assembly pathway$333,360
R01 · FY2011 · AI · contact PI
Regulation of APOBEC3G enzymatic activity in HIV-infected primary human T cells$394,886
R01 · FY2010 · AI · contact PI
The role of cellular factors in the HIV-1 capsid assembly pathway$336,727
R01 · FY2010 · AI · contact PI
Regulation of APOBEC3G enzymatic activity in HIV-infected primary human T cells$213,763
R01 · FY2010 · AI · contact PI
Regulation of APOBEC3G enzymatic activity in HIV-infected primary human T cells$398,875
R01 · FY2009 · AI · contact PI
The role of cellular factors in the HIV-1 capsid assembly pathway$340,128
R01 · FY2009 · AI · contact PI
The role of cellular factors in the HIV-1 capsid assembly pathway$330,956
R01 · FY2009 · AI · contact PI
Regulation of APOBEC3G enzymatic activity in HIV-infected primary human T cells$373,500
R56 · FY2008 · AI · contact PI
The role of cellular factors in the HIV-1 capsid assembly pathway$340,128
R01 · FY2008 · AI · contact PI
The role of cellular factors in the HIV-1 capsid assembly pathway$321,372
R01 · FY2007 · AI · contact PI
Role of a Host Protein in HIV Particle Formation$254,248
R01 · FY2006 · AI · contact PI
Cell-free VEE assembly system and alphavirus drug screen$180,764
R21 · FY2006 · AI · contact PI
Role of a Host Protein in HIV Particle Formation$260,556
R01 · FY2005 · AI
Cell-free VEE assembly system and alphavirus drug screen$223,014
R21 · FY2005 · AI
Role of a Host Protein in HIV Particle Formation$360,402
R01 · FY2004 · AI
Role of a Host Protein in HIV Particle Formation$283,334
R01 · FY2003 · AI
Role of a Host Protein in HIV Particle Formation$261,193
R01 · FY2002 · AI
ASSEMBLY OF HIV CAPSIDE IN A CELL FREE SYSTEM$63,215
R29 · FY2001 · AI
ASSEMBLY OF HIV CAPSIDE IN A CELL FREE SYSTEM$93,140
R29 · FY2000 · AI